Dr. Reddy's Bio-Sciences Limited

Dr. Reddy's Bio-Sciences Limited - chemicals and materials in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U72200TG2000PLC034765 Incorporated 27 June 2000 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Public Limited Company chemicals and materials
Revenue · FY 2026
₹2.7 Cr
▲ 125% YoY
Net profit · FY 2026
₹88.4 Lakh
Net margin 32.7%
EBITDA · FY 2026
₹1.21 Cr
EBITDA margin 44.9%
Authorised capital
₹90 Cr
Registered with MCA
Paid-up capital
₹89.83 Cr
Issued & subscribed
Satisfied charges
₹1.5 Cr
No open charges
Company age
26 yrs
Est. 2000
Directors on board
3
As per MCA filings

About Dr. Reddy's Bio-Sciences Limited

Data last updated:

Dr. Reddy's Bio-Sciences Limited is a public limited company based in Hyderabad, Telangana, India, a subsidiary of Dr.Reddy's Laboratories Ltd. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 27 June 2000 and has been in existence for over 26 years.

Its director K Satish Reddy and family are #223 among India's richest people (2026).

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U72200TG2000PLC034765.

The company has an authorised share capital of ₹90 Cr and a paid-up capital of ₹89.83 Cr. It is led by directors including Satish Reddy Kallam and Seema Grover.

Its last annual general meeting (AGM) was held on 21 July 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 8 – 2 – 337 Road No. 3 Banjara Hills, Hyderabad, Telangana, India – 500034.

As per the financials filed for FY 2026, the company reported a revenue of ₹2.7 Cr, a growth of 125% compared to the previous year. For the same year it recorded a net profit of ₹88.4 Lakh (net margin 32.7%) and EBITDA of ₹1.21 Cr (EBITDA margin 44.9%). Revenue has grown at a compounded annual rate (CAGR) of 218% over three years and 118% over five years.

The company is associated with 1 brand: Dr. Reddy's Laboratories. As per MCA filings, the company has satisfied charges of ₹1.5 Cr on record. Court records list 63 cases involving the company, including 35 filed by the company and 28 filed against it; 24 cases are pending.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website drreddys.com.

Company details

CIN U72200TG2000PLC034765
Registration Number 034765
Incorporation Date 27 June 2000
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Parent Company Dr.Reddy's Laboratories Ltd
Compliance Status Active Compliant

CIN history

Dr. Reddy's Bio-Sciences has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U72200TG2000PLC034765, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U72200TG2000PLC034765Current
L72200AP2000PLC034765Previous
U72200AP2000PLC034765Previous

Recognitions & Rankings of Dr. Reddy's Bio-Sciences

Contact details

Dr. Reddy's Bio-Sciences Limited's registered office is in Hyderabad, Telangana. Its website is drreddys.com. Its e-mail address is in the company report.

  • Email
  • Social Media
  • Registered Address
    8 – 2 – 337 Road No. 3 Banjara Hills, Hyderabad, Telangana, India – 500034
  • Industry
    Chemicals and Materials, Industrial Chemicals

To see the full contact details of Dr. Reddy's Bio-Sciences Limited, buy the company report.

Comprehensive company report
Dr. Reddy's Bio-Sciences Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Dr. Reddy's Bio-Sciences operates one associated brand: Dr. Reddy's Laboratories. Each brand links to its own profile.

BrandDescriptionWebsite
Innovative medicines are developed and manufactured globally by the company.drreddys.com

Financials of Dr. Reddy's Bio-Sciences Limited

FY 2026 filings available

Dr. Reddy's Bio-Sciences Limited reported revenue of ₹2.7 Cr (up 125% YoY) for FY 2026.

Revenue · FY 2026
₹2.7 Cr ▲ 125%
Net profit · FY 2026
₹88.4 Lakh margin 32.7%
EBITDA · FY 2026
₹1.21 Cr margin 44.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 125%
3 years · compounded
▲ 218%
5 years · compounded
▲ 118%
EBITDA CAGR growth
1 year
▲ 113%

Revenue has grown at a compounded annual rate (CAGR) of 118% over five years, including 125% growth in the latest year. EBITDA rose 113% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹2.7 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.21 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹88.4 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin44.9%
Net Profit Margin32.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Dr. Reddy's Bio-Sciences Limited, buy the company report.

Board of directors of Dr. Reddy's Bio-Sciences Limited

Dr. Reddy's Bio-Sciences has 3 current directors and 19 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Satish Reddy KallamDirector06 Jul 200323 Years 4 MonthsCurrent
Seema GroverDirector08 Nov 20224 Years 0 MonthsCurrent
Jesal AgarwalAdditional Director24 Nov 20250 Years 11 MonthsCurrent

Peer comparison

Dr. Reddy's Bio-Sciences Limited is compared with the 10 companies closest to it by revenue in the Chemicals industry (Industrial Chemicals), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Dr. Reddy's Bio-Sciences Limitedthis company₹2.7 Cr (FY 2026)₹88.4 Lakh32.7%125.0%Hyderabad, Telangana, India
Chintamani Fine Chem Private Limited₹1.21 Cr (FY 2025)1.0%Mumbai, Maharashtra, India
Athos Chemicals Private Limited₹1.21 Cr (FY 2024)532.0%Surat, Gujarat, India
Soor Colour Fresh Private Limited₹1.21 Cr (FY 2025)-9.0%Surat, Gujarat, India
Junneng Chemicals India Private Limited₹1.21 Cr (FY 2025)-19.0%Ahmedabad, Gujarat, India
Gujarat Sulphur Ltd₹1.2 Cr (FY 2024)-64.0%Ahmedabad, Gujarat, India
Bioindus Enterprises Private Limited₹1.2 Cr (FY 2024)4.0%Thane, Maharashtra, India
Marvelore Mining and Allied Industries Private Limited₹1.2 Cr (FY 2025)0.0%Porbandar, Gujarat, India
Constance Indichrom Private Limited₹1.2 Cr (FY 2025)9.0%Chennai, Tamil Nadu, India
Immk Chemtech Private Limited₹1.2 Cr (FY 2025)13.0%Thane, Maharashtra, India
Glaceon Chemicals Private Limited₹1.2 Cr (FY 2024)59.0%Kalol, Gujarat, India

To see the full peer comparison of Dr. Reddy's Bio-Sciences Limited, buy the company report.

Auditor

Dr. Reddy's Bio-Sciences Limited is audited by ALKA ZANWAR & CO for the financial year 2026.

Auditor firmFinancial yearFirm registration number
ALKA ZANWAR & COFY 2026000501S

Shareholding

The shareholding of Dr. Reddy's Bio-Sciences Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2026FY 2025FY 2024FY 2023FY 2022
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Dr. Reddy's Bio-Sciences Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹1.5 Cr
Breakdown by lending institutions
Icici Bank Ltd.₹1.50 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
27 Sep 200090257082Icici Bank Ltd.₹1.5 CrSatisfied

To see the full charge records of Dr. Reddy's Bio-Sciences Limited, buy the company report.

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Dr. Reddy's Bio-Sciences Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Dr. Reddy's Bio-Sciences Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Dr. Reddy's Bio-Sciences Limited has 18 board changes on record since 2003: 6 appointments and 12 cessations. The latest: Jesal Agarwal was appointed as Additional Director on 24 Nov 2025.

Filing
Dr. Reddy'S Bio-Sciences Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Hyderabad.
Appointed
Jesal Agarwal was appointed as Additional Director.
AGM
Dr. Reddy'S Bio-Sciences Limited last Annual general meeting of members was held on 21 Jul 2025 as per latest MCA records.
Appointed
Vijay Kumar Hurgat was appointed as CFO.
Ceased
Venkatanarasimham Mannam ceased to be CFO.
Appointed
Ashok Kalyan Tavva was appointed as CEO.
Ceased
Pankaj Mahajan ceased to be CEO.
Ceased
Amit Parekh ceased to be Additional Director.
Appointed
Amit Parekh was appointed as Director.
Appointed
Seema Grover was appointed as Director.
Ceased
Viswanath Vemuri ceased to be Ceo(Kmp).
Ceased
Kiran Yanamandra ceased to be Additional Director.

11 earlier events are in the company report.

Frequently asked questions

Dr. Reddy's Bio-Sciences is an active public limited company based in Hyderabad, Telangana, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 27 June 2000 (26+ years old) and is registered under CIN U72200TG2000PLC034765.

Dr. Reddy's Bio-Sciences has 3 current directors:

The latest financial statements of Dr. Reddy's Bio-Sciences on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 21 July 2025. Year-wise statements from 2015 are in the company report.

The CIN (Corporate Identification Number) of Dr. Reddy's Bio-Sciences is U72200TG2000PLC034765. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Dr. Reddy's Bio-Sciences has 63 court cases on record: 35 filed by the company and 28 filed against it. 24 are pending. Most are in the district courts.

Dr. Reddy's Bio-Sciences was incorporated on 27 June 2000, making it 26+ years old. It is registered with the Registrar of Companies, Hyderabad.

The peers of Dr. Reddy's Bio-Sciences by revenue are Chintamani Fine Chem Private Limited, Athos Chemicals Private Limited, Soor Colour Fresh Private Limited, Junneng Chemicals India Private Limited, Gujarat Sulphur Ltd and 5 more, all in the Chemicals industry (Industrial Chemicals).

Jesal Agarwal was appointed as Additional Director on 24 Nov 2025. Vijay Kumar Hurgat was appointed as CFO on 20 Jan 2025. Venkatanarasimham Mannam ceased to be CFO on 30 Jul 2024. Dr. Reddy's Bio-Sciences has 18 board changes on record in total.

Dr. Reddy's Bio-Sciences can be reached through the website drreddys.com. Its registered office is in Hyderabad, Telangana, India.

The registered office of Dr. Reddy's Bio-Sciences is at 8 – 2 – 337 Road No. 3 Banjara Hills, Hyderabad, Telangana, India – 500034.

Dr. Reddy's Bio-Sciences operates in the chemicals and materials industry, in the industrial chemicals segment.